Institut für Laboratoriumsmedizin, Klinische Chemie und Pathobiochemie
Profiling of Endo H-released serum N-glycans using CE-LIF and MALDI-TOF-MS--application to rheumatoid arthritis.
Quantitative MALDI-TOF-MS Using Stable- isotope Labeling: Application to the Analysis of N-glycans of Recombinant Alpha-1 Antitrypsin Produced Using Different Culture Parameters.
Protein Glycosylation and Its Impact on Biotechnology..
GNE is involved in the early development of skeletal and cardiac muscle.
Construction and analysis of a novel peptide tag containing an unnatural N-glycosylation site.
N-glycosylation and biological activity of recombinant human alpha1-antitrypsin expressed in a novel human neuronal cell line.
Interaction of human dipeptidyl peptidase IV and human immunodeficiency virus type-1 transcription transactivator in Sf9 cells.
Production of Non-fucosylated Antibodies by Co-Expression of Heterologous GDP-6-deoxy-D-lyxo-4-hexulose reductase.
N-Glycan Analysis of Recombinant L-Selectin Reveals Sulfated GalNAc and GalNAc-GalNAc Motifs.
Characterization of ligand binding to N-acetylglucosamine kinase studied by STD NMR.
Dr. rer. nat. Markus Berger
Charité – Universitätsmedizin Berlin
Institut für Laboratoriumsmedizin, Klinische Chemie und Pathobiochemie
Campus Charité Mitte
Charitéplatz 1
D-10117 Berlin
Fon: +49 (0)30 450 569 103
Fax: +49 (0)30 450 569 906